| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/05/1999 | DE19804251A1 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Biphenylsulfonylcyanamide, processes for their preparation and their use as a medicament |
| 08/05/1999 | CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318830A1 Derivatives of 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318443A1 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
| 08/05/1999 | CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis |
| 08/05/1999 | CA2318215A1 Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist |
| 08/05/1999 | CA2317459A1 Methods of identifying modulators of kinases responsive to stress |
| 08/05/1999 | CA2313226A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders |
| 08/04/1999 | EP0933373A1 Terpenoid lactone compounds and their production process |
| 08/04/1999 | EP0933351A1 Tricyclic retinoids, methods for their production and use |
| 08/04/1999 | EP0933350A1 Tricyclic retinoids, methods for their production and use |
| 08/04/1999 | EP0932608A1 SELECTIVE FACTOR Xa INHIBITORS |
| 08/04/1999 | EP0932606A1 Inhibitors of prenyl transferases |
| 08/04/1999 | EP0932410A1 Mistletoe (viscum) extracts |
| 08/04/1999 | EP0932403A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 08/04/1999 | EP0932399A1 Water soluble paclitaxel prodrugs |
| 08/04/1999 | EP0932395A1 Methods and compositions employing red yeast fermentation products |
| 08/04/1999 | EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 08/04/1999 | EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 08/04/1999 | EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/04/1999 | EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
| 08/04/1999 | CN1224720A Tetracylic derivatives, process of preparation and use |
| 08/04/1999 | CN1224718A Thiazole derivatives |
| 08/04/1999 | CN1224715A Cycloalkano-indote and againdole derivatives, process for their preparation and pharmaceutical composition containing the same |
| 08/04/1999 | CN1044479C Process for preparation of anti-thrombin polypeptides |
| 08/03/1999 | US5932765 Nitromethyl ketones, process for preparing them and compositions containing them |
| 08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
| 08/03/1999 | US5932730 Endothelin antagonist |
| 08/03/1999 | US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs. |
| 08/03/1999 | US5932701 ribA |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932593 Antiserotonin agent |
| 08/03/1999 | US5932587 Heterocyclic-fused pyridines |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions |
| 08/03/1999 | US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 08/03/1999 | US5932575 Cardiac diseases improving agents |
| 08/03/1999 | US5932565 Vitamin D analogues |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
| 08/03/1999 | US5932548 Lysine containing peptides for treatment of heart disease |
| 08/03/1999 | US5932244 Liposomal human calcitonin gene-related peptide composition and preparation of the same |
| 08/03/1999 | US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine |
| 08/03/1999 | CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 07/29/1999 | WO1999037651A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/29/1999 | WO1999037637A1 Benzamide derivatives as vasopressin antagonists |
| 07/29/1999 | WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/29/1999 | WO1999037607A1 Potassium channel inhibitors |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| 07/29/1999 | WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | WO1999037170A1 Dietetic composition in the form of a substitution salt for table salt |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | CA2319242A1 Dietetic composition in the form of a substitution salt for table salt |
| 07/29/1999 | CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317457A1 Potassium channel inhibitors |
| 07/28/1999 | EP0931788A2 Metalloprotease inhibitors |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931087A1 Novel pyranoside derivatives |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0931056A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0737189B1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | EP0604494B1 5-ht4 receptor antagonists |
| 07/28/1999 | CN1224464A Growth factor and genetic sequence encoding same |
| 07/28/1999 | CN1224424A Azolobenzazepine derivs. as neurologically active agents |
| 07/28/1999 | CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/28/1999 | CN1223803A Health-care tea and its preparing process |
| 07/27/1999 | US5929249 Angiotensin ii receptor antagonists |
| 07/27/1999 | US5929123 Antioxidant compounds |
| 07/27/1999 | US5929112 Use in pharmaceuticals or cosmetics as antioxidants, improved bioavailability |
| 07/27/1999 | US5929092 Lipophilic benzothiophenes for treating estrogen deficiency |
| 07/27/1999 | US5929078 Antiserotonine agent |
| 07/27/1999 | US5929075 Apolipoprotein-B synthesis inhibitors |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929039 Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928641 Having binding specificity for crossreactive epitopes shared by endoglin expressed on human vascular endothelial cells and endoglin expressed on murine vascular endothelial cells |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |